Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $400
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Barclays analyst Emily Field maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $380 to $400.
Barclays analyst Emily Field maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $380 to $400.